Cite Filings / NTLA / 0001193125-20-308366
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
424B5

Prospectus

Intellia Therapeutics, Inc. · Filed 2020-12-02 · Acc 0001193125-20-308366

Documents 1

  • 424B5 Prospectus , d85337d424b5.htm

Around this filing

  • 2021-06-28 424B5 Prospectus
  • 2020-12-03 4 EVP, General Counsel sold 3,364 shares at an average $38.21 ($128,525)
  • 2020-12-02 8-K Material agreement · Other events
  • 2020-12-02 424B5 Prospectus
  • 2020-11-30 424B5 Prospectus
  • 2020-11-30 S-3ASR Registration Statement
  • 2020-11-27 4 President and CEO sold 35,000 shares at an average $38.57 ($1,350,000)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading d85337d424b5.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…